FDA Panel votes in favor of a $949 Cancer detecting blood test, but is Galleri ready for approval?

Economic Times - Sep 25, 2026

Cancer cells can leave tiny fragments of DNA in the bloodstream. According to USA Today, Galleri studies chemical patterns found on these fragments. A machine-learning system then analyzes the results for signals that could point to cancer.

Read full article
More News
Copyright © 2015 - 2026 The Financial Capital.

All Rights Reserved.

Subscribe Now!

About Us

The Financial Capital is your independent source for finance information and advice. We provide insights and offer advice from financial experts so you can make the best decisions.